Cargando…
Identification of a high incidence region for retroviral vector integration near exon 1 of the LMO2 locus
Therapeutic retroviral vector integration near the oncogene LMO2 is thought to be a cause of leukemia in X-SCID gene therapy trials. However, no published studies have evaluated the frequency of vector integrations near exon 1 of the LMO2 locus. We identified a high incidence region (HIR) of vector...
Autores principales: | Yamada, Koichiro, Tsukahara, Tomonori, Yoshino, Kazuhisa, Kojima, Katsuhiko, Agawa, Hideyuki, Yamashita, Yuki, Amano, Yuji, Hatta, Mariko, Matsuzaki, Yasunori, Kurotori, Naoki, Wakui, Keiko, Fukushima, Yoshimitsu, Osada, Ryosuke, Shiozawa, Tanri, Sakashita, Kazuo, Koike, Kenichi, Kumaki, Satoru, Tanaka, Nobuyuki, Takeshita, Toshikazu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2742512/ https://www.ncbi.nlm.nih.gov/pubmed/19725963 http://dx.doi.org/10.1186/1742-4690-6-79 |
Ejemplares similares
-
Murine Leukemias with Retroviral Insertions at Lmo2 Are Predictive of the Leukemias Induced in SCID-X1 Patients Following Retroviral Gene Therapy
por: Davé, Utpal P., et al.
Publicado: (2009) -
Biochemical Feature of LMO2 Interactome and LMO2 Function Prospect
por: Wang, Wenhao, et al.
Publicado: (2020) -
A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease
por: Amano, Yuji, et al.
Publicado: (2019) -
Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds
por: Canning, Peter, et al.
Publicado: (2021) -
Biology and management of lobular endocervical glandular hyperplasia
por: Miyamoto, Tsutomu, et al.
Publicado: (2022)